Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Tolerability and Pharmacokinetics of GST-HG141 Tablets in Single-center, Randomized, Double-blind, Placebo-controlled Multiple-dose, Single-dose, Multiple-dose Phase Ia Clinical Trials in Healthy Subjects

NCT04386915 is registered in ClinicalTrials.gov with Fujian Cosunter Pharmaceutical Co. Ltd as lead sponsor.

NCT NCT04386915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04386915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Tolerability and Pharmacokinetics of GST-HG141 Tablets in Single-center, Randomized, Double-blind, Placebo-controlled Multiple-dose, Single-dose, Multiple-dose Phase Ia Clinical Trials in Healthy Subjects
Lead sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Phase
Phase 1
Overall status
Unknown status
Start date
May 18, 2020
Completion date
August 1, 2021
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b